This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Angela Tam: Innovator in Combination Therapy
Introduction
Angela Tam is a prominent inventor based in Randolph, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the area of combination therapies for treating proliferative diseases. Her innovative approach has led to the development of a unique pharmaceutical product that combines specific inhibitors to enhance treatment efficacy.
Latest Patents
Angela Tam holds 1 patent related to her work on combination therapy. The patent details a pharmaceutical product that comprises a combination of a MET inhibitor, specifically INC280 or a pharmaceutically acceptable salt or hydrate thereof, and an EGFR inhibitor. This combination is designed to be jointly active in the treatment of proliferative diseases, along with corresponding pharmaceutical formulations, uses, methods, processes, commercial packages, and related embodiments.
Career Highlights
Angela is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on innovative solutions in the pharmaceutical industry. She has demonstrated a strong commitment to advancing medical treatments through her research and development efforts.
Collaborations
Angela has collaborated with notable colleagues, including Xizhong Huang and Huaixiang Hao. These partnerships have contributed to her success in developing effective pharmaceutical products.
Conclusion
Angela Tam is a trailblazer in the field of combination therapy, with her innovative patent showcasing her dedication to improving treatment options for patients. Her work at Novartis AG and collaborations with esteemed colleagues further highlight her impact on the pharmaceutical industry.